These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20127826)

  • 1. Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics.
    Mahmood I
    J Pharm Sci; 2010 Jul; 99(7):2927-33. PubMed ID: 20127826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misconceptions and issues regarding allometric scaling during the drug development process.
    Mahmood I
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):843-854. PubMed ID: 29999428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies in allometric scaling for predicting human drug clearance: an historical problem and reflections on what works and what does not.
    Tang H; Mayersohn M
    Curr Top Med Chem; 2011; 11(4):340-50. PubMed ID: 21320063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.
    Mahmood I; Tegenge MA
    Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Tissue to Plasma Concentration Ratios of Drugs in the Rat from Experimentally Estimated Volume of Distribution: Application of Allometry.
    Mahmood I
    Curr Drug Metab; 2018; 19(2):155-164. PubMed ID: 29189141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspective.
    Tang H; Hussain A; Leal M; Fluhler E; Mayersohn M
    J Pharm Sci; 2011 Feb; 100(2):402-10. PubMed ID: 20862773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allometric exponents do not support a universal metabolic allometry.
    White CR; Cassey P; Blackburn TM
    Ecology; 2007 Feb; 88(2):315-23. PubMed ID: 17479750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interspecies scaling for the prediction of drug clearance in children: application of maximum lifespan potential and an empirical correction factor.
    Mahmood I
    Clin Pharmacokinet; 2010 Jul; 49(7):479-92. PubMed ID: 20528008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of drug clearance in children: impact of allometric exponents, body weight, and age.
    Mahmood I
    Ther Drug Monit; 2007 Jun; 29(3):271-8. PubMed ID: 17529882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of drug clearance in children 3 months and younger: an allometric approach.
    Mahmood I
    Drug Metabol Drug Interact; 2010; 25(1-4):25-34. PubMed ID: 21417791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
    Mahmood I
    J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically-Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate.
    Wu Q; Peters SA
    CPT Pharmacometrics Syst Pharmacol; 2019 Apr; 8(4):220-229. PubMed ID: 30762304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study.
    Mahmood I
    J Pharm Pharmacol; 1999 Aug; 51(8):905-10. PubMed ID: 10504028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods.
    Mahmood I; Yuan R
    Biopharm Drug Dispos; 1999 Apr; 20(3):137-44. PubMed ID: 10211866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human pharmacokinetic parameters using animal data and principles of allometry. A case using bicifadine, a non-narcotic analgesic, as an example.
    Srinivas NR; Ahlawat P
    Arzneimittelforschung; 2009; 59(12):625-30. PubMed ID: 20108647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of fixed exponent 0.75 to the prediction of human drug clearance: an inaccurate and misleading concept.
    Mahmood I
    Drug Metabol Drug Interact; 2009; 24(1):57-81. PubMed ID: 19354001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.